Medimix International Expands Its Executive Team
Jean-Jacques Borie Joins as Senior VP Innovation
Miami, FL (Jan. 9, 2018) – In a newly created position reporting directly to Medimix CEO, Henry Gazay, Jean-Jacques’ mission is to accelerate the development of Medimix’s innovative, cloud-based Real World Evidence suite of solutions and to enhance the experience of its various stakeholders (Customers, HCPs and Patients). He will spearhead the company’s innovation efforts so that Medimix platforms remain incrementally superior to the competition, while converging towards global interoperability standards.
“I was impressed by Jean-Jacques’ track record in delivering innovative solutions in complex, cloud-based ecosystems, as well as his wide knowledge of the big data environment,” declared Henry Gazay. “With Medimix expanding at a double-digit growth rate and becoming a recognized global player in Real World Evidence for specialty medicine, Jean Jacques’ talent will be instrumental in helping us tackle new challenges, such as interoperability with the recent FDA and EMA standards, compatibility with new industry ecosystems such as Amazon Healthcare machine learning, and integration of Patient Reported Outcomes mobile platforms.”
A computer science engineer (CNAM 07), Jean-Jacques holds an MSIT from Ecole des Mines and HEC Paris, and an executive TRIUM Global EMBA from HEC / NYU Stern / LSE. He has spent over two decades advancing state-of-the-art technology in the application platform industry. In each of his prior positions, he has demonstrated a great level of skill in digital platform design and played a key role in the companies’ furthered success.
Prior to joining Medimix, he held a range of technology executive positions with multiple leading and innovative companies, including Leade.rs, Digitas LBi (Publicis), Kantar and BBDO and worked for investors such as Reid Hoffman (founder of LinkedIn), Eric Schmidt (Google Chairman), Marissa Mayer (Yahoo CEO) or David Marcus (head of Facebook Messenger).
“Joining a leader in the healthcare analytics industry is a new and fascinating challenge“ commented Jean-Jacques. “The more I am talking with Henry and his team, the more I am convinced that our collaboration will generate exponential value for Medimix customers and for patients suffering from chronic diseases.”
About Medimix International
Medimix is a global technology company that specializes in providing business understanding, Real World Evidence insights and information support to the pharmaceutical, diagnostic, and medical device industries. Our solutions leverage big data and evidence-based information, to advise and support business decisions in forecasting, marketing, commercial analytics, business intelligence, health economics, medical affairs, strategy and licensing.
Medimix has offices and teams in 12 cities around the globe: United States – Boston, San Francisco, and NJ; EU – Paris, London, and Basel; LatAm – Montevideo, Uruguay and Sao Paulo, Brazil; Asia: Bacolod, Hong-Kong, Tokyo and Shanghai.
For more information go to www.medimix.net